Related Experiment Videos
Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders
The British Journal of Dermatology
|August 14, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dry or wet? Fluid therapy in upper gastrointestinal surgery patients.
Updates in surgery·2022
Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients.
Frontiers in immunology·2020
Resistance of Transgenic Prunus domestica to Plum Pox Virus Infection.
Plant disease·2019
Insights into Pathogenesis of Chronic Spontaneous Urticaria.
The British journal of dermatology·2026
Beyond the First Graft: Skin Cancer Risk and Risk Stratification in Retransplanted Solid Organ Recipients.
The British journal of dermatology·2026
Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.
The British journal of dermatology·2026
Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients.
The British journal of dermatology·2026
Randomised Controlled Feasibility Trial of an Intervention to Reduce Infant Bathing.
The British journal of dermatology·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026